medulloblastoma
Stanford Medicine Laboratory for Cell and Gene Medicine Awarded Grant for CAR T-Cell Platform
The lab will use the G-Rex platform to manufacture a CAR T-cell therapy for a Phase I clinical trial.
Contrasting the experience of three young patients, researchers suggested that a germline ATM mutation may be linked to poor radiation therapy outcomes.
Adding Chemo to Radiation Therapy Improves Outcomes for Certain Medulloblastoma Patients, Study Finds
Researchers found the addition of carboplatin to radiotherapy improved survival by 19 percent for patients with group 3 medulloblastoma.
Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy
The study found certain patients did not benefit from lower doses of radiation therapy, suggesting the need for molecular selection.
Though some experts prefer the comprehensive nature of whole-genome sequencing, others find whole-exome sequencing or targeted exome panels to be more useful.